Preclinical Efficacy of Experimental Peptide Therapy Suggests a New Target for Metastatic Breast Cancer Treatments, UTHealth Houston Researchers Find | Newswise

Likely AI

www.newswise.comby University of Texas Health Science Center at HoustonApril 29, 2026Submitted April 30, 2026

A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat metastatic breast cancer in humans, UTHealth Houston researchers have discovered.

The Verdict

ClassificationLikely AI

ConfidenceHigh confidence

Analyzedtext

Community Verdict

Be the first to vote on this assessment.

Embed Badge

Add this badge to your site to show the AI classification for this content.

[![Real Press](https://real.press/api/badge/5ca6ec21-404d-47ff-8f32-b826223cd150)](https://real.press/content/5ca6ec21-404d-47ff-8f32-b826223cd150)